Sphera Funds Management Ltd. Cogent Biosciences, Inc. Transaction History

Sphera Funds Management Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $652,843 - $1.62 Million	-160,799 Reduced 38.29%	259,201 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.24 $1.18 Million - $1.59 Million	120,000 Added 40.0%	420,000 $4.97 Million
Q1 2023 May 15, 2023	BUY	$10.04 - $15.5 $3.01 Million - $4.65 Million	300,000 New	300,000 $3.24 Million
Q2 2021 Aug 17, 2021	SELL	$7.82 - $9.3 $5.96 Million - $7.09 Million	-762,569 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.47 - $12.34 $202,698 - $334,845	27,135 Added 3.69%	762,569 $6.7 Million
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $6.65 Million - $9.57 Million	735,434 New	735,434 $8.26 Million

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $612M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.